Henneicke-von Zepelin H, Hentschel C, Schnitker J, et al. Efficacy and safety of a fixed combination phytomedicine in the treatment of the common cold (acute viral respiratory tract infection): results of a randomised, double blind, placebo controlled, multicentre study.
Curr Med Res Opin. 2000;15:214–27.
Wustenberg P, Henneicke-von Zepelin HH, Kohler G, et al. Efficacy and mode of action of an immunomodulator herbal preparation containing
Echinacea, wild indigo, and white cedar.
Adv Ther. 1999;16:51–70.
Hauke W, Kohler G, Henneicke-Von Zepelin HH, et al. Esberitox N as supportive therapy when providing standard antibiotic treatment in subjects with a severe bacterial infection (acute exacerbation of chronic bronchitis). A multicentric, prospective, double-blind, placebo-controlled study.
Egert D, Beuscher N. Studies on antigen specifity of immunoreactive arabinogalactan proteins extracted from
Planta Med. 1992;58:163–5.
Wagner H, Jurcic K. Immunologic studies of plant combination preparations. In-vitro and in-vivo studies on the stimulation of phagocytosis [in German].
Beuscher N, Scheit KH, Bodinet C, et al. Immunologically active glycoproteins of
Planta Med. 1989;55:358–63.
Naser B, Lund B, Henneicke-von Zepelin HH, et al. A randomized, double-blind, placebo-controlled, clinical dose-response trial of an extract of Baptisia, Echinacea and Thuja for the treatment of patients with common cold.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.